{
    "clinical_study": {
        "@rank": "50237", 
        "arm_group": [
            {
                "arm_group_label": "Inhaled steroids (Budicort)", 
                "arm_group_type": "Experimental", 
                "description": "Inhaled Budicort"
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Inhaled NS 0.9%"
            }
        ], 
        "brief_summary": {
            "textblock": "Transient Tachypnea of the Newborn (TTN) is a common respiratory disorder affecting late\n      preterm and term babies caused by lung edema resulting from delayed absorption of fetal\n      alveolar lung fluid.\n\n      The investigators hypothesize that ENAC expression will be up-regulated as a result of\n      administration of corticosteroids. This effect will lead to enhanced absorption of fetal\n      lung fluid finally treating TTN. The aim of our study will be to evaluate whether inhaled\n      corticosteroids reduce respiratory distress and morbidity in late preterm and term neonates\n      presenting with TTN."
        }, 
        "brief_title": "Inhaled Corticosteroids for the Treatment of Transient Tachypnea of the Newborn", 
        "condition": "Transient Tachypnea of the Newborn", 
        "detailed_description": {
            "textblock": "The primary outcome measure will be the assessment of respiratory distress reflected by TTN\n      clinical score in neonates presenting with TTN and treated with inhaled corticosteroids\n      compared to placebo."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Late preterm and term infants (post-menstrual age \u2265 34 weeks) delivered by cesarean\n             section or vaginal delivery\n\n          -  Diagnosis of TTN\n\n          -  Parents signed informed consent\n\n        Exclusion Criteria:\n\n          -  Meconium aspiration syndrome\n\n          -  Respiratory distress syndrome\n\n          -  Congenital heart disease\n\n          -  Non respiratory disorders causing tachypnea"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "6 Hours", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "56", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01858129", 
            "org_study_id": "0090-11-BNZ"
        }, 
        "intervention": [
            {
                "arm_group_label": "Inhaled steroids (Budicort)", 
                "description": "Inhaled Budicort twice daily", 
                "intervention_name": "Experimental group: Budicort by Inhalation", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Control", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "TTN", 
        "lastchanged_date": "May 20, 2013", 
        "location": {
            "contact": {
                "email": "amirkug@gmail.com", 
                "last_name": "Amir Kugelman, MD", 
                "phone": "972-4-8359559"
            }, 
            "contact_backup": {
                "email": "davidbade@gmail.com", 
                "last_name": "David Bader, MD", 
                "phone": "972-4-8359559"
            }, 
            "facility": {
                "address": {
                    "city": "Haifa", 
                    "country": "Israel"
                }, 
                "name": "Bnai Zion Medical Center"
            }, 
            "investigator": {
                "last_name": "David Bader, MD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "Inhaled Corticosteroids for the Treatment of Transient Tachypnea of the Newborn in Infants Born at >34 Weeks Gestation: A Prospective, Randomized, Double Blind, Placebo Controlled Study.", 
        "other_outcome": {
            "description": "Blood pressure measurements", 
            "measure": "Will follow blood pressure", 
            "safety_issue": "Yes", 
            "time_frame": "An average time period expected to be 5 days, according to the duration of hospital stay"
        }, 
        "overall_contact": {
            "email": "amirkug@gmail.com", 
            "last_name": "Amir Kugelman, MD"
        }, 
        "overall_contact_backup": {
            "email": "davidbade@gmail.com", 
            "last_name": "David Bader, MD"
        }, 
        "overall_official": {
            "affiliation": "Bnai Zion Medical Center", 
            "last_name": "Amir Kugelman, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary outcome measure will be the assessment of respiratory distress reflected by TTN clinical score in neonates presenting with TTN and treated with inhaled corticosteroids compared to placebo at 12, 24 and 48 hours after the first dose of inhaled study medication.", 
            "measure": "Assessment of respiratory distress", 
            "safety_issue": "No", 
            "time_frame": "48 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01858129"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Bnai Zion Medical Center", 
            "investigator_full_name": "Kugelman Amir", 
            "investigator_title": "Head, Pediatric Pulmonary Unit", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The secondary outcome will be the assessment of morbidity associated with TTN as reflected by time to spontaneous unsupported breathing of room air (hours), time to spontaneous breathing (LFNC and/or FiO2<0.3) for infants who got a higher level of respiratory support,  maximal level of respiratory support (no oxygen, intra-incubator oxygen, LFNC, nCPAP, NIPPV, high flow nasal canulla, SIMV, HFOV), LOS (days), TFF (hours),  need and length of antibiotic therapy in the study vs. placebo groups.", 
            "measure": "The secondary outcome will be the assessment of morbidity associated with TTN", 
            "safety_issue": "No", 
            "time_frame": "An average time period expected to be 5 days, according to the duration of hospital stay"
        }, 
        "source": "Bnai Zion Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bnai Zion Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}